Nectin-4 targeted PDC (Medshine Discovery)

靶向Nectin‑4多肽偶联物（南京明德新药）

Report date: 2026/05/21 20:00:22

NME

Base Information

Drug NameNectin-4 targeted PDC (Medshine Discovery)

Drug Alias NameN/A

ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > VC linker

Mechanisms of ActionNectin-4 bindersTubulin inhibitors

TargetsNectin-4Tubulin

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesMedshine Discovery Inc

China Registration ClassN/A

Develop Information

Active CompaniesMedshine Discovery Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A